Snehal Shah

Snehal Shah

Directeur Technique/Scientifique/R&D chez OCULIS HOLDING AG
Commercial Services
Consumer Services
Health Technology

Profil

Snehal Shah currently works at Oculis Holding AG, as President-Research & Development from 2024.
Dr. Shah also formerly worked at Noven Pharmaceuticals, Inc., as Member-Hisamitsu Group from 2012 to 2017, Kyowa Kirin Co., Ltd., as Senior Vice President-Regulatory Affairs from 2017 to 2021, and IVERIC bio, Inc., as SVP, Chief Regulatory & Product Strategy Officer.
Dr. Shah received his doctorate degree from the University of Kansas and undergraduate degree from Rutgers University- Newark.

Postes actifs de Snehal Shah

SociétésPosteDébut
OCULIS HOLDING AG Directeur Technique/Scientifique/R&D 10/04/2024

Anciens postes connus de Snehal Shah

SociétésPosteFin
KYOWA KIRIN CO., LTD. Conseiller Juridique Général 01/01/2021
Corporate Officer/Principal 01/01/2017
IVERIC BIO, INC. Conseiller Juridique Général -
Voir l'expérience en détail de Snehal Shah

Formation de Snehal Shah

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

45

Relations au 1er degré

6

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées6

Commercial Services

Consumer Services

Health Technology

Health Technology

Consumer Services

Commercial Services

  1. Bourse
  2. Insiders
  3. Snehal Shah
🔇